A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2002
12/18/2002	CN1385205A Soft-extract for treating hepatitis B and preparation process thereof
12/18/2002	CN1385203A Compound Chinese medicine preparation of damnacanthus
12/18/2002	CN1385201A Formula of solid antitussive soft-extract and preparation method thereof
12/18/2002	CN1385192A Oral health care products using extreated mung bean juice as mother liquor and preparation method thereof
12/18/2002	CN1385191A Medicine for treating liver disease
12/18/2002	CN1385190A Medicine for treating liver disease
12/18/2002	CN1385183A Medicine for treating fatty liver
12/18/2002	CN1385179A Changbao oral liquor for intestine health care
12/18/2002	CN1385178A Acupuncture point plaster for antihepatitis
12/18/2002	CN1385174A Forestfrog oil tonic
12/18/2002	CN1385171A Traditional Chinese medicine for treating enterogastric disease
12/18/2002	CN1385166A Medicine for treating vertigo
12/18/2002	CN1385159A Doxycycline vibramycin enteric soluble preparation for treating peridentitis
12/18/2002	CN1385156A Application of anethole trithione in pharmacy
12/18/2002	CN1096460C Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for treatment of allergic diseases
12/18/2002	CN1096459C (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1, 4-diazepin-6-YL)-2-methoxy-6-methylamino-3-pyridine-carboxamide
12/18/2002	CN1096277C Perfume liquid extract capable of improving indoor air and regulating qi and blood
12/18/2002	CN1096275C External-use Chinese medicine for treating bagy diarrhea
12/18/2002	CA2388761A1 Wound healing biomarkers
12/17/2002	US6495687 Adenosine receptors are involved in a vast number of peripheral and central regulatory mechanisms such as, for example, vasodilation, cardiac depression, inhibition of lipolysis, inhibition of insulin release and potentiation
12/17/2002	US6495606 Administering s-((r)-2-(1-iminoethylamino)propyl)-l-cysteine
12/17/2002	US6495590 Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations
12/17/2002	US6495589 An amino acid derivative useful to increase secretion of growth hormone (gh) from the anterior pituitary of mammals, including on sustained release basis
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495571 Administering to the mammal an effective cancer treatment amount of the compound 3,5-dichloro-4,6-diethoxy-2-(trichloromethyl)pyridine or and acid addition salt to treat the cancer
12/17/2002	US6495567 Triaryl methane compounds and their use in the treatment of diarrhea and scours
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth
12/17/2002	US6495560 10,11-dihydro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1 -ethoxy)-5h-dibenzo(a,d)cycloheptene-10-acetic acid; treatment of osteoporosis
12/17/2002	US6495555 Tricyclic Δ-3-piperidines as α2-antagonists
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495547 Hampered or impaired relaxation of the fundus to food ingestion; irritable bowel syndrome, anorexia, bloating, early satiety, dyspepsia
12/17/2002	US6495546 Propanolamine derivatives
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	US6495543 Treating or preventing melatoninergic disorders
12/17/2002	US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/17/2002	US6495525 N-((4-(((2-methylphenylamino)carbonyl)amino)phenyl)acetyl)-l -prolyl-3-methyl)-beta-alanine; very late antigen-4 cell adhesion inhibitor; inflammation and immune reactions
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495148 High molecular weight polyuronic acids used as moisturizers and for prevention of skin disorders, ulcers, wrinkles, dryness or aging
12/17/2002	CA2061675C Quinoline-containing ketoacids as leukotriene antagonists
12/15/2002	CA2390327A1 Method
12/14/2002	CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002098907A2 Cation conducting gabaa receptors and their use
12/12/2002	WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002	WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
12/12/2002	WO2002098876A1 Cak inhibitors and uses thereof
12/12/2002	WO2002098875A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098872A1 Isoindolines and process for preparation thereof
12/12/2002	WO2002098871A1 Phenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
12/12/2002	WO2002098863A1 Fused imidazole derivative
12/12/2002	WO2002098857A1 New indole derivatives with 5-ht6 receptor affinity
12/12/2002	WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002	WO2002098433A1 Drugs for intestinal diseases
12/12/2002	WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002	WO2002098426A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
12/12/2002	WO2002098424A1 Novel anti-infectives
12/12/2002	WO2002098423A1 S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
12/12/2002	WO2002098422A1 Use of methylnaltrexone to treat immune suppression
12/12/2002	WO2002098405A1 Liver fibrosis inhibitors
12/12/2002	WO2002098398A1 Methods for preventing and treating diseases and conditions associated with cellular stress
12/12/2002	WO2002098352A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
12/12/2002	WO2002098348A2 Glp-1 formulations with protracted time action
12/12/2002	WO2002087600A8 Use of phyllanthus constituents for treating or preventing infections caused by hepatit
12/12/2002	WO2002083879A3 Immunotherapy based on dendritic cells
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002074798A3 The genome of a bifidobacterium
12/12/2002	WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002	WO2002068015A9 Modular infusion device and method
12/12/2002	WO2002066458A3 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
12/12/2002	WO2002064591A3 Carboline derivatives
12/12/2002	WO2002064552A8 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002061052A3 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
12/12/2002	WO2002045686A3 Pharmaceutical paste comprising an acid-labile active ingredient
12/12/2002	WO2002032898A3 Novel anticholinergics, method for the production thereof and use thereof as medicaments
12/12/2002	WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002	WO2001097850A3 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/12/2002	WO2001078720A8 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
12/12/2002	WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002	WO2001042272A9 Eplerenone crystalline form exhibiting enhanced dissolution rate
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188029 Methods of treating or preventing weight gain, obesity, and related disorders
12/12/2002	US20020188016 Heterocycle derivatives and methods of use
12/12/2002	US20020188009 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
12/12/2002	US20020188008 Novel salt form of pantoprazole
12/12/2002	US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187994 New compounds
12/12/2002	US20020187991 Barbituric acid derivatives
12/12/2002	US20020187947 Inflammation-related gene
12/12/2002	US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002	US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B

1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 1258